Skip to main content
OliX Pharmaceuticals, Inc. logo

OliX Pharmaceuticals, Inc. — Investor Relations & Filings

Ticker · 226950 ISIN · KR7226950004 KO Manufacturing
Open in API
Filings indexed 365 across all filing types
Latest filing 2021-11-15 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 226950

About OliX Pharmaceuticals, Inc.

https://olixpharma.com

OliX Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company specializing in the development of therapeutics based on RNA interference (RNAi) technology. The company leverages its proprietary asymmetric siRNA (asiRNA) platform to create treatments that selectively silence disease-causing genes. Its research and development efforts are focused on building a robust pipeline of drug candidates targeting a variety of illnesses with high unmet medical needs. The pipeline has a particular emphasis on ophthalmic and dermal disorders, with key programs addressing conditions such as hypertrophic scars, age-related macular degeneration (AMD), and other fibrotic and ocular diseases.

Recent filings

Filing Released Lang Actions
분기보고서 (2021.09)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for the company OliX Pharmaceuticals, covering the period from January 1, 2021, to September 30, 2021. It contains detailed corporate information, financial data, business descriptions, and management discussions, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2021
2021-11-15 Korean
기타경영사항(자율공시)((국책과제 선정 (감염병 예방·치료 기술개발사업)))
Regulatory Filings Classification · 100% confidence The document is a voluntary disclosure ('자율공시') by the company Olix regarding its selection for a government-funded research project ('국책과제 선정'). It details the project name, research institution, duration, budget, and expected impact. Since this is a specific corporate announcement regarding business operations and project funding that does not fit into the other specialized categories like M&A, dividends, or financial reports, it is classified as a general regulatory filing.
2021-11-01 Korean
주요사항보고서(유형자산양수결정)
Regulatory Filings Classification · 100% confidence The document is a 'Major Asset Acquisition' (유형자산 양수 결정) filing submitted to the Korea Exchange (KRX). It details the acquisition of land and buildings by Olix Co., Ltd., including the purpose, financial details, and board approval. This type of regulatory disclosure regarding significant corporate transactions falls under the 'Regulatory Filings' category as it is a specific material event report required by the exchange.
2021-10-27 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report on Large Shareholding' (주식등의 대량보유상황보고서) filed by Mirae Asset Global Investments regarding their stake in the company 'Olix'. This type of filing is a standard regulatory requirement when an entity crosses a 5% ownership threshold in a publicly traded company. In the provided classification schema, this corresponds to a 'Major Shareholding Notification'.
2021-10-22 Korean
투자판단관련주요경영사항(GalNAc-asiRNA 기술을 이용한 Collaboration and License Agreement 체결)
Regulatory Filings Classification · 100% confidence The document is a formal regulatory filing from a Korean company (OliX) regarding a 'Collaboration and License Agreement' (a technology export/licensing deal). It details the contract terms, financial milestones, and strategic partnership details. In the context of Korean stock exchange filings (DART), this is classified as a 'Major Management Matter' (주요경영사항), which falls under the category of general regulatory announcements for material corporate events that do not fit into specific categories like M&A or share issuance.
2021-10-12 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a formal announcement regarding the scheduling and logistics of an upcoming Investor Relations (IR) presentation/meeting. It provides the date, time, location (online), and purpose of the event. Since it is an announcement of an event rather than the presentation slides themselves, and it does not fit into specific categories like 'Call Transcript' or 'Annual Report', it falls under the general regulatory announcement category for corporate events.
2021-10-05 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.